Evidence map›Paper›PMID 27413002›Full record

ArticleInfluenza and other respiratory viruses2016

Pulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study.

Pål Voltersvik, Lara A Aqrawi, Susanne Dudman, Olav Hungnes, Norwegian Lung Pathology Group, Leif Bostad, Karl A Brokstad, Rebecca J Cox

Open access · goldAbstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Article
  4. Autopsies in pandemics - a perspective on barriers and benefits. Is it time for a revival?APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2021
    Review
  5. Article
  6. Pulmonary Vascular Manifestations of COVID-19 Pneumonia.Radiology. Cardiothoracic imaging · 2020
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Pål VoltersvikThe Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Lara A AqrawiThe Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Susanne DudmanWHO National Influenza Centre, Norwegian Institute of Public Health, Oslo, Norway.
Olav HungnesWHO National Influenza Centre, Norwegian Institute of Public Health, Oslo, Norway.
Norwegian Lung Pathology Group
Leif BostadGade Laboratory for Pathology, Department of Clinical Medicine, Haukeland University Hospital, University of Bergen, Bergen, Norway.
Karl A BrokstadThe Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.
Rebecca J CoxThe Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway. Rebecca.Cox@uib.no.
Haukeland University Hospital · NONorwegian Institute of Public Health · NOUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring the pandemic outbreak of the 2009 swine influenza (A(H1N1)pdm09), 32 fatal cases occurred in Norway and 19 of these were included in this study.

objectivesWe characterised pulmonary changes in these fatal Norwegian cases. PATIENTS AND

methodsUpon hospitalisation, detailed clinical information and specimens from the upper and lower respiratory pathways were collected. At post-mortem, lung tissue was collected, formalin-fixed and paraffin-embedded. Immunohistochemical and light microscopic examination was performed to visualise the local expression of the A(H1N1)pdm09 virus. Reverse transcription-polymerase chain reaction (RT-PCR) and pyrosequencing of the non-fixed specimens allowed the identification of mutations in the influenza virus surface glycoprotein (haemagglutinin gene) particularly at position 222. RESULTS AND

conclusionsThe overall course of illness lasted from 2 to 40 days (median 9 days). Diffused alveolar damage (DAD) was evident in 11 cases, 4 of which had no apparent underlying illness. Obesity was prominent in 12 cases, where three individuals were classified as otherwise healthy. The HA D222G mutation was detected in six cases, 3 of which had no underlying illness. Immunohistochemistry showed the A(H1N1)pdm09 virus to be prominent at the site of inflammation both in close proximity to and inside alveolar structures in the lung tissue. In addition to a possible role for the HA D222G mutation, our findings indicate that host factors and underlying conditions in the infected individuals are fundamental for disease outcome in many cases. This study increases our understanding of determinants for the clinical outcome of pandemic influenza, which could guide future treatment.

Indexed as

AdolescentAdultAgedChildFemaleHigh-Throughput Nucleotide SequencingHospitalizationHost-Pathogen InteractionsHumansImmunohistochemistryInfluenza A Virus, H1N1 SubtypeInfluenza, HumanLungMaleMiddle AgedMutationRNA, Viral2009 pandemicHA pyrosequencingimmunohistochemistryinfluenzalung

Identifiers

PMID27413002
PMCPMC5059952
OpenAlexW2473301064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.